You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API mesalamine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing mesalamine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc DELZICOL mesalamine 0023-5853 DIBUTYL SEBACATE
Allergan Inc DELZICOL mesalamine 0023-5853 FERRIC OXIDE RED
Allergan Inc DELZICOL mesalamine 0023-5853 FERRIC OXIDE YELLOW
Allergan Inc DELZICOL mesalamine 0023-5853 HYPROMELLOSES
Allergan Inc DELZICOL mesalamine 0023-5853 LACTOSE MONOHYDRATE
Allergan Inc DELZICOL mesalamine 0023-5853 MAGNESIUM STEARATE
Allergan Inc DELZICOL mesalamine 0023-5853 METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing mesalamine

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc mesalamine 0093-5907 DIBUTYL SEBACATE
Teva Pharmaceuticals USA Inc mesalamine 0093-5907 FERRIC OXIDE RED
Teva Pharmaceuticals USA Inc mesalamine 0093-5907 FERROSOFERRIC OXIDE
Teva Pharmaceuticals USA Inc mesalamine 0093-5907 HYPROMELLOSE
Teva Pharmaceuticals USA Inc mesalamine 0093-5907 LACTOSE MONOHYDRATE
Teva Pharmaceuticals USA Inc mesalamine 0093-5907 MAGNESIUM STEARATE
Teva Pharmaceuticals USA Inc mesalamine 0093-5907 METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for mesalamine

Excipient focus: ACETYLTRIBUTYL CITRATE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS CITRIC ACID

mesalamine drug variants containing ANHYDROUS CITRIC ACID

Company Ingredient NDC
Teva Pharmaceuticals USA Inc mesalamine 0093-9224
Aphena Pharma Solutions - Tennessee LLC mesalamine 43353-884
Physicians Total Care Inc mesalamine 54868-6150
Bryant Ranch Prepack mesalamine 63629-8827
Salix Pharmaceuticals Inc mesalamine 65649-103
Oceanside Pharmaceuticals mesalamine 68682-113
Lupin Pharmaceuticals Inc mesalamine 70748-214
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: ASPARTAME

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

Excipient focus: CARBOXYMETHYLCELLULOSE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CARNAUBA WAX

Excipient focus: CASTOR OIL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CERIC OXIDE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSPOVIDONE

mesalamine drug variants containing CROSPOVIDONE

Company Ingredient NDC
Teva Pharmaceuticals USA Inc mesalamine 0093-9224
Aphena Pharma Solutions - Tennessee LLC mesalamine 43353-884
Bryant Ranch Prepack mesalamine 63629-8827
Salix Pharmaceuticals Inc mesalamine 65649-103
Oceanside Pharmaceuticals mesalamine 68682-113
Lupin Pharmaceuticals Inc mesalamine 70748-214
Pharma Packaging Solutions LLC dba Tjoapack LLC mesalamine 75929-137
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: D&C RED NO. 22

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIACETYLATED MONOGLYCERIDES

Excipient focus: DIBUTYL PHTHALATE

Excipient focus: DIBUTYL SEBACATE

Excipient focus: DIMETHICONE

Excipient focus: EDETATE DISODIUM

Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER

Excipient focus: ETHYLCELLULOSE

mesalamine drug variants containing ETHYLCELLULOSE

Company Ingredient NDC
Mylan Pharmaceuticals Inc mesalamine 0378-1375
Upsher-Smith Laboratories LLC mesalamine 0832-6056
Ingenus Pharmaceuticals LLC mesalamine 50742-371
American Health Packaging mesalamine 60687-703
Sun Pharmaceutical Industries Inc mesalamine 63304-089
Zydus Pharmaceuticals USA Inc mesalamine 68382-452
Zydus Lifesciences Limited mesalamine 70771-1625
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: FAT, HARD

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C GREEN NO. 3

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HARD FAT

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSE PHTHALATE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHACRYLIC ACID

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

mesalamine drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Company Ingredient NDC
Allergan Inc mesalamine 0023-5853
Meda Pharmaceuticals Inc mesalamine 0037-0022
Meda Pharmaceuticals Inc mesalamine 0037-0066
Teva Pharmaceuticals USA Inc mesalamine 0093-5907
Teva Pharmaceuticals USA Inc mesalamine 0093-9224
Mylan Pharmaceuticals Inc mesalamine 0378-1375
Mylan Pharmaceuticals Inc mesalamine 0378-9230
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: NONOXYNOL-100

Excipient focus: PETROLATUM

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM ACETATE

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POTASSIUM METABISULFITE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

mesalamine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Meda Pharmaceuticals Inc mesalamine 0037-0022
Meda Pharmaceuticals Inc mesalamine 0037-0066
Teva Pharmaceuticals USA Inc mesalamine 0093-9224
Mylan Pharmaceuticals Inc mesalamine 0378-1375
Mylan Pharmaceuticals Inc mesalamine 0378-9230
Actavis Pharma Inc mesalamine 0472-1915
Teva Pharmaceuticals Inc mesalamine 0480-7750
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

mesalamine drug variants containing STEARIC ACID

Company Ingredient NDC
Takeda Pharmaceuticals America Inc mesalamine 54092-100
Takeda Pharmaceuticals America Inc mesalamine 54092-189
Takeda Pharmaceuticals America Inc mesalamine 54092-476
American Health Packaging mesalamine 60687-703
Sun Pharmaceutical Industries Inc mesalamine 63304-089
Carilion Materials Management mesalamine 68151-4769
Avera McKennan Hospital mesalamine 69189-0189
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: VANILLIN

Excipient focus: WATER

Excipient focus: WHITE WAX

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group